Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM6B | O15054 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.50 |
| ▸ | RECQL | P46063 | 3/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.50 |
| ▸ | LCK | P06239 | 2/20 | 0.50 |
| ▸ | USP2 | O75604 | 2/20 | 0.50 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.50 |
| ▸ | HTR2A | P28223 | 2/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.50 |
| ▸ | EGFR | P00533 | 1/20 | 0.50 |
| ▸ | FYN | P06241 | 1/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.50 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 4/20 | 0.48 |
| ▸ | CA2 | P00918 | 4/20 | 0.48 |
| ▸ | MME | P08473 | 1/20 | 0.46 |
| ▸ | ACE | P12821 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29024434 | 0.81 | MME (0.49) | MMECYP1A2FOLH1 | |
| SCHEMBL30724831 | 0.79 | KDM6B (0.64) | KDM6BKDM4EALOX15HIF1AHSD17B10 | |
| SCHEMBL29669984 | 0.77 | KDM6B (0.62) | KDM6BKDM4EALOX15HIF1AHSD17B10 | |
| SCHEMBL5063603 | 0.77 | KDM6B (0.62) | KDM6BKDM4EALOX15HIF1AHSD17B10 | |
| SCHEMBL29429645 | 0.77 | KDM6B (0.62) | KDM6BKDM4EALOX15HIF1AHSD17B10 | |
| SCHEMBL30915529 | 0.76 | KDM6B (0.60) | KDM6BKDM4EALOX15HIF1AHSD17B10 | |
| SCHEMBL32662363 | 0.76 | KDM6B (0.60) | KDM6BKDM4EALOX15HIF1AHSD17B10 | |
| SCHEMBL31284349 | 0.76 | KDM6B (0.65) | KDM6BKDM4EALOX15HIF1AHSD17B10 | |
| SCHEMBL3736877 | 0.76 | KDM6B (0.60) | KDM6BKDM4EALOX15HIF1AHSD17B10 | |
| SCHEMBL22473033 | 0.76 | CA2 (0.61) | KDM6BKDM4EALOX15HIF1AHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260041764-A1 | EXTRACELLULAR VESICLES FOR VACCINE DELIVERY | LONZA SALES AG (CH) | 2026-02-12 | — | — | US | disclosed |
| US-12502427-B2 | Extracellular vesicles for vaccine delivery | LONZA SALES AG (CH) | 2025-12-23 | — | — | US | disclosed |
| EP-3068439-B1 | OLIGOPEPTIDE AND METHODS FOR PRODUCING CONJUGATES THEREOF | HOFFMANN LA ROCHE (CH) | 2024-06-26 | — | — | EP | disclosed |
| US-11992527-B2 | Extracellular vesicles for vaccine delivery | LONZA SALES AG (CH) | 2024-05-28 | — | — | US | disclosed |
| US-20240108747-A1 | EXTRACELLULAR VESICLE CONJUGATES AND USES THEREOF | LONZA SALES AG (CH) | 2024-04-04 | — | — | US | disclosed |
| US-20230263885-A1 | EXTRACELLULAR VESICLES FOR VACCINE DELIVERY | CODIAK BIOSCIENCES, INC. (US) | 2023-08-24 | — | — | US | disclosed |
| CN-109897089-B | Integrin ligand VS polypeptide and application thereof in preparation of tumor targeting diagnosis and treatment drug delivery system | 复旦大学 | 2023-08-22 | — | — | CN | disclosed |
| US-20220168415-A1 | EXTRACELLULAR VESICLES FOR VACCINE DELIVERY | CODIAK BIOSCIENCES, INC. (US) | 2022-06-02 | — | — | US | disclosed |
| EP-3941937-A2 | EXTRACELLULAR VESICLES FOR VACCINE DELIVERY | Codiak BioSciences, Inc. (US) | 2022-01-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260041764-A1 | EXTRACELLULAR VESICLES FOR VACCINE DELIVERY | EXOSC10, EXOSC5, HLA-DRB1 | KDM6B 2294/4885KDM4E 1894/4885ALOX15 3331/4885 |
| US-12502427-B2 | Extracellular vesicles for vaccine delivery | HAVCR2, CD74, HMGB1 | KDM6B 1966/4885KDM4E 2469/4885ALOX15 2166/4885 |
| US-11992527-B2 | Extracellular vesicles for vaccine delivery | HAVCR2, CD74, HMGB1 | KDM6B 1966/4885KDM4E 2469/4885ALOX15 2166/4885 |
| US-20240108747-A1 | EXTRACELLULAR VESICLE CONJUGATES AND USES THEREOF | EXOSC5, EXOSC10, EXOSC4 | KDM6B 851/4885KDM4E 1452/4885ALOX15 3485/4885 |
| US-20230263885-A1 | EXTRACELLULAR VESICLES FOR VACCINE DELIVERY | HAVCR2, CD74, HMGB1 | KDM6B 1966/4885KDM4E 2469/4885ALOX15 2166/4885 |
| US-20220168415-A1 | EXTRACELLULAR VESICLES FOR VACCINE DELIVERY | HAVCR2, CD74, HMGB1 | KDM6B 1966/4885KDM4E 2469/4885ALOX15 2166/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.